Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof | Patent Number 11884674

US 11884674 B2
Application Number17858826
Publication NumberUS 20220340583 A1
Pendency1 year, 6 months, 28 days
Filled DateJul 6, 2022
Priority DateAug 15, 2017
Publication DateOct 27, 2022
Expiration DateAug 14, 2037
Inventor/ApplicantsLai Wang
Yunhang Guo
Yunhang GUO
Zhiwei WANG
Zhiwei Wang
Gongyin Shi
Gongyin SHI
ExaminesRAO, SAVITHA M
Art Unit1629
Technology Center1600
Assignments
Beigene Ltd.
Current
Beigene Ltd.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.